Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term Open-label Study in Patients With Interstitial Lung Disease Associated With Systemic Sclerosis Who Completed the Protocol AC-052-330.

NCT00319033 is registered in ClinicalTrials.gov with Actelion as lead sponsor.

NCT NCT00319033
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00319033 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term Open-label Study in Patients With Interstitial Lung Disease Associated With Systemic Sclerosis Who Completed the Protocol AC-052-330.
Lead sponsor
Actelion
Phase
Phase 2/3
Overall status
Completed
Start date
July 31, 2004
Completion date
February 28, 2006
Enrollment
132
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

interstitial lung disease, scleroderma